This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European prosthetic vascular grafts market. Major topics covered by this report include an overview of selected cardiovascular diseases and disorders (e.g., aneurysm, coronary heart disease, diabetes, hypertension, and stroke); cardiovascular disease management options; and a discussion of products, competitors, and forecast markets for prosthetic vascular graft segments including endovascular stent-grafts for aortic aneurysm repair, hemodialysis access grafts, peripheral vascular grafts, and small-diameter CABG grafts.
EXECUTIVE SUMMARY i. Prosthetic Vascular Grafts a. Applications b. Product Categories c. Hemodialysis Access Grafts d. Endovascular Stent-Grafts for Aortic Aneurysm Repair e. Peripheral Vascular Grafts f. Small-Diameter Coronary Artery Bypass Grafts g. Combined Market Analysis Exhibit ES-1: Europe, Hemodialysis Access Grafts, Market Forecast, by Country, 2012-2017 Exhibit ES-2: Europe, Endovascular Stent-Grafts for Abdominal and Thoracic Aortic Aneurysm Repair, Market Forecast, by Country, 2012-2017 Exhibit ES-3: Europe, Peripheral Vascular Grafts, Market Forecast, by Country, 2012-2017 Exhibit ES-4: Europe, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, by Country, 2012-2017 Exhibit ES-5: Europe, Prosthetic Vascular Grafts, Combined Market Forecast, by Country, 2012-2017 1. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES/DISORDERS 1.1 Cardiovascular Diseases/Disorders 1.1.1 Coronary Heart Disease 220.127.116.11 Atherosclerosis 18.104.22.168.1 Description 22.214.171.124.2 Statistics 126.96.36.199 Angina Pectoris 188.8.131.52.1 Description 184.108.40.206.2 Statistics 220.127.116.11 Myocardial Infarction 18.104.22.168.1 Description 22.214.171.124.2 Statistics 1.1.2 Hypertension 126.96.36.199 Description 188.8.131.52 Statistics 1.1.3 Aneurysm 184.108.40.206 Description 220.127.116.11 Statistics 1.1.4 Stroke 18.104.22.168 Description 22.214.171.124 Statistics 1.1.5 Diabetes 126.96.36.199 Description 188.8.131.52 Statistics 1.2 Cardiovascular Disease Management Options 1.2.1 Medical Management 184.108.40.206 Lifestyle Changes 220.127.116.11.1 Dietary Modification 18.104.22.168.2 Smoking Cessation 22.214.171.124 Pharmaceuticals 126.96.36.199.1 Anticoagulants and Antiplatelet Drugs 188.8.131.52.2 Lipid-Lowering Drugs 184.108.40.206.3 Antihypertensive Drugs 220.127.116.11.4 Nitroglycerin Preparations 1.2.2 Intracoronary Heart Disease Diagnosis 18.104.22.168 Coronary Angiography 22.214.171.124.1 Description 126.96.36.199.2 Statistics 1.2.3 Coronary Artery Disease Treatment 188.8.131.52 Coronary Artery Bypass Graft Surgery 184.108.40.206.1 Less Invasive Coronary Artery Bypass Graft Techniques 220.127.116.11 Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting 18.104.22.168 Peripheral Percutaneous Revascularization Techniques 22.214.171.124.1 Percutaneous Transluminal Angioplasty and Peripheral Stenting 126.96.36.199.2 Peripheral Atherectomy 188.8.131.52.3 Peripheral Femoropopliteal Stenting Exhibit 1-1: Number of Deaths due to Cardiovascular Diseases/Disorders, by Gender Exhibit 1-2: 2008, Prevalence of Hypercholesterolemia, by Gender Exhibit 1-3: Standard Angina Pectoris Classification Exhibit 1-4: 30-Day Case Fatality Rates Following Hospital Admission for Acute Myocardial Infarction, Selected European Countries Exhibit 1-5: 2008, Prevalence of Hypertension, by Gender Exhibit 1-6: Stroke, Hospital Discharge Rates, 2000 and 2009 Exhibit 1-7: 2008, Prevalence of Elevated Blood Glucose, by Gender Exhibit 1-8: 2007, Daily Per-Person Consumption of Fats, Fruits, and Vegetables Exhibit 1-9: Tobacco Smoking Rate, by Gender Exhibit 1-10: 2006/2007, Medication at Discharge for Patients with Coronary Heart Disease, Selected European Countries Exhibit 1-11: 2007, Cardiac Catheterization Laboratories and Coronary Angiography Procedures, Selected European Countries Exhibit 1-12: 2010, Coronary Artery Bypass Graft Surgery, Selected European Countries, by Type Exhibit 1-13: 2010, Percutaneous Coronary Intervention/Stenting Procedures, Selected European Countries, by Type Exhibit 1-14: 2010, Peripheral Vascular Disease Treatment Procedures, Selected European Countries, by Type 2. THE EUROPEAN PROSTHETIC VASCULAR GRAFTS MARKET 2.1 Prosthetic Vascular Grafting Applications 2.1.1 Aneurysm 2.1.2 Kidney Failure 2.1.3 Vascular Occlusion 2.2 Prosthetic Vascular Graft Categorization 2.2.1 Categorization by Graft Diameter 184.108.40.206 Large-Diameter Grafts 220.127.116.11 Medium-Diameter Grafts 18.104.22.168 Small-Diameter Grafts 2.2.2 Categorization by Graft Material 22.214.171.124 Polyester 126.96.36.199 Polytetrafluoroethylene 188.8.131.52 Polyurethane 184.108.40.206 Biological 220.127.116.11.1 Human Saphenous and Umbilical Veins 18.104.22.168.2 Tissue-Engineered Materials 2.2.3 Endovascular Stent-Grafts 22.214.171.124 Performance Requirements 126.96.36.199 Configurations 188.8.131.52 Endovascular Stent-Graft-Related Complications 2.3 Prosthetic Vascular Grafts Market 2.3.1 Market Drivers and Limiters 2.3.2 Hemodialysis Access Grafts 184.108.40.206 Market Forecast 220.127.116.11 Competitive Analysis 2.3.3 Endovascular Stent-Graft Systems for Aortic Aneurysm Repair 18.104.22.168 Market Forecast 22.214.171.124 Competitive Analysis 2.3.4 Peripheral Vascular Grafts 126.96.36.199 Market Forecast 188.8.131.52 Competitive Analysis 2.3.5 Small-Diameter Coronary Artery Bypass Grafts 184.108.40.206 Market Forecast 220.127.116.11 Competitive Analysis 2.3.6 Combined Market Forecast Exhibit 2-1: Indications for the Use of Prosthetic Vascular Grafts Exhibit 2-2: Interventions for the Treatment of Peripheral Vascular Occlusions Exhibit 2-3: Design Criteria for Synthetic Vascular Grafts Exhibit 2-4: Applications for Prosthetic Vascular Grafts, by Diameter Exhibit 2-5: 2013, Selected Polyester Vascular Grafts Exhibit 2-6: 2013, Selected Polytetrafluoroethylene Vascular Grafts Exhibit 2-7: 2013, Selected Polyurethane Vascular Grafts Exhibit 2-8: Design Specifications for Endovascular Stent-Graft Systems Exhibit 2-9: Complications Associated with the Use of Endovascular Stent-Grafts for Abdominal Aortic Aneurysm Repair Exhibit 2-10: 2013, Selected Endovascular Stent-Grafts for Aortic Aneurysm Repair Exhibit 2-11: Europe, Hemodialysis Access Grafts, Market Forecast, by Country, 2012-2017 Exhibit 2-12: 2012, Europe, Hemodialysis Access Grafts Market, Share by Supplier Exhibit 2-13: Europe, Endovascular Stent-Grafts for Abdominal and Thoracic Aortic Aneurysm Repair, Market Forecast, by Country, 2012-2017 Exhibit 2-14: 2012, Europe, Endovascular Abdominal Aortic Aneurysm Stent-Grafts Market, Share by Supplier Exhibit 2-15: 2012, Europe, Endovascular Thoracic Aortic Aneurysm Stent-Grafts Market, Share by Supplier Exhibit 2-16: Europe, Peripheral Vascular Grafts, Market Forecast, by Country, 2012-2017 Exhibit 2-17: 2012, Europe, Peripheral Vascular Grafts Market, Share by Supplier Exhibit 2-18: Europe, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, by Country, 2012-2017 Exhibit 2-19: 2012, Europe, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier Exhibit 2-20: Europe, Prosthetic Vascular Grafts, Combined Market Forecast, by Country, 2012-2017 3. COMPANY PROFILES 3.1 Atrium Medical Corporation/Getinge Group AB 3.2 C.R. Bard, Inc. 3.3 Cook Group, Inc. 3.4 W.L. Gore & Associates, Inc. 3.5 Maquet Vascular Interventions/Getinge Group AB 3.6 Medtronic, Inc. 3.7 Vascutek LTD/Terumo Corporation APPENDIX: COMPANY LISTING